BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 1370867)

  • 1. Cocaine/polydrug use in pregnancy: two-year follow-up.
    Chasnoff IJ; Griffith DR; Freier C; Murray J
    Pediatrics; 1992 Feb; 89(2):284-9. PubMed ID: 1370867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polydrug-using adolescent mothers and their infants receiving early intervention.
    Field TM; Scafidi F; Pickens J; Prodromidis M; Pelaez-Nogueras M; Torquati J; Wilcox H; Malphurs J; Schanberg S; Kuhn C
    Adolescence; 1998; 33(129):117-43. PubMed ID: 9583666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of three-year data.
    Azuma SD; Chasnoff IJ
    Pediatrics; 1993 Sep; 92(3):396-402. PubMed ID: 7689727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal drug exposure: effects on neonatal and infant growth and development.
    Chasnoff IJ; Burns KA; Burns WJ; Schnoll SH
    Neurobehav Toxicol Teratol; 1986; 8(4):357-62. PubMed ID: 3762846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year outcome of children exposed prenatally to drugs.
    Griffith DR; Azuma SD; Chasnoff IJ
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):20-7. PubMed ID: 7511139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine-exposed children: follow-up through 30 months.
    Hurt H; Brodsky NL; Betancourt L; Braitman LE; Malmud E; Giannetta J
    J Dev Behav Pediatr; 1995 Feb; 16(1):29-35. PubMed ID: 7730454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants.
    Weathers WT; Crane MM; Sauvain KJ; Blackhurst DW
    Pediatrics; 1993 Feb; 91(2):350-4. PubMed ID: 8424009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal cocaine/polydrug exposure: effect of race on outcome.
    Billman DO; Nemeth PB; Heimler R; Sasidharan P
    J Perinatol; 1996; 16(5):366-9. PubMed ID: 8915935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of in utero substance exposure on infant neurobehavior.
    Napiorkowski B; Lester BM; Freier MC; Brunner S; Dietz L; Nadra A; Oh W
    Pediatrics; 1996 Jul; 98(1):71-5. PubMed ID: 8668415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal nonnarcotic substance abuse during pregnancy: effects on infant development.
    Chasnoff IJ; Schnoll SH; Burns WJ; Burns K
    Neurobehav Toxicol Teratol; 1984; 6(4):277-80. PubMed ID: 6514088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natal status of infants of cocaine users and control subjects: a prospective comparison.
    Hurt H; Brodsky NL; Braitman LE; Giannetta J
    J Perinatol; 1995; 15(4):297-304. PubMed ID: 8558338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth outcomes for infants of drug abusing mothers.
    Kaye K; Elkind L; Goldberg D; Tytun A
    N Y State J Med; 1989 May; 89(5):256-61. PubMed ID: 2733887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromotor development of cocaine-exposed and control infants from birth through 15 months: poor and poorer performance.
    Fetters L; Tronick EZ
    Pediatrics; 1996 Nov; 98(5):938-43. PubMed ID: 8909489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis.
    Fares I; McCulloch KM; Raju TN
    J Perinatol; 1997; 17(3):179-82. PubMed ID: 9210070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse in pregnancy.
    Feng T
    Curr Opin Obstet Gynecol; 1993 Feb; 5(1):16-23. PubMed ID: 8425031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological correlates of fetal cocaine exposure: transient hypertonia of infancy and early childhood.
    Chiriboga CA; Vibbert M; Malouf R; Suarez MS; Abrams EJ; Heagarty MC; Brust JC; Hauser WA
    Pediatrics; 1995 Dec; 96(6):1070-7. PubMed ID: 7491223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine use in pregnancy.
    Chasnoff IJ; Burns WJ; Schnoll SH; Burns KA
    N Engl J Med; 1985 Sep; 313(11):666-9. PubMed ID: 4022059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopment of adopted children exposed in utero to cocaine.
    Nulman I; Rovet J; Altmann D; Bradley C; Einarson T; Koren G
    CMAJ; 1994 Dec; 151(11):1591-7. PubMed ID: 7954158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.